Immunization News and Research

RSS

mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone

Researchers assessed the chances of COVID-19 hospitalization after three versus two mRNA vaccine doses.

28 Sep 2022

Researchers computationally design immunogens to elicit antibodies against different SARS-CoV-2 variants

A recent study designed immunogens to induce antibodies against SARS-CoV-2 variants.

28 Sep 2022

What is the vaccine efficacy of repeated influenza vaccinations?

In a new study, researchers calculated the decrease in vaccine effectiveness due to repeated influenza vaccinations.

27 Sep 2022

What is the association between COVID-19 and type 1 diabetes?

In a new study, researchers assessed the relationship between incident type 1 diabetes and recent coronavirus disease 2019 (COVID-19) Infection.

27 Sep 2022

First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine

In a recent study posted to the bioRxiv* preprint server, researchers from Germany and the United States analyzed the association between exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.4/BA.5 spike glycoprotein and pan-Omicron neutralization.

27 Sep 2022

What is the efficacy of the BCG vaccine against SARS-CoV-2 infection?

In a new study, researchers assessed the ecological association suggesting the efficacy of bacillus Calmette-Guerin (BCG) vaccination against COVID-19.

22 Sep 2022

Virology of the human monkeypox virus

A new review to be posted in the Virus Research journal aims to provide an overview of the recent advances reported concerning hMPXV virology.

21 Sep 2022

Prophylactic administration of SARS-CoV-2 specific immunoglobulin Y generated in chicken eggs displays protective effects in infected mice

A new study characterized and tested the antibody activity of SARS-CoV-2-specific immunoglobulin Y (IgY) derived from the eggs laid by chickens immunized with recombinant SARS-CoV-2 receptor binding domain (RBD) protein.

21 Sep 2022

Researchers report development of a self-assembled trimeric RBD subunit vaccine able to prevent SARS-CoV-2 infection

The present study reported the development of a new self-assembled trimeric RBD subunit vaccine that could effectively prevent infection from SARS-CoV-2 variants, including the currently dominantly circulating Omicron variant.

21 Sep 2022

Study reveals improved immunogenicity and safety of bivalent Omicron-containing mRNA-1273.214 candidate booster vaccine

In a new study, a team of researchers assessed the safety and efficacy of a bivalent candidate vaccine containing spike messenger ribonucleic acids of the ancestral Wuhan-Hu-1 strain and the Omicron B.1.1.529 [BA.1] variant of SARS-CoV-2.

21 Sep 2022

United States joins 30 other countries with circulating vaccine-derived poliovirus

CDC today announced that polioviruses found in New York, both from the case of paralytic polio in an unvaccinated adult in Rockland County and in several wastewater samples from communities near the patient's residence, meet the World Health Organization (WHO)'s criteria for circulating vaccine-derived poliovirus (cVDPV) – meaning that poliovirus continues to be transmitted in Rockland County, NY, and surrounding areas.

19 Sep 2022

The potential for measles and rubella elimination globally

Researchers modeled the probability of eradication of measles and rubella by 2100.

19 Sep 2022

An improved COVID-19 vaccine shows promise against Omicron in experimental models

In a recent study published in the journal Science Translational Medicine, researchers in the United States designed a bivalent coronavirus disease 2019 (COVID-19) vaccine on the messenger ribonucleic acid (mRNA) platform.

18 Sep 2022

COVID-19 vaccine safety concerns result in lower vaccination rates among pregnant individuals in the United States

In a new study, researchers evaluated the factors associated with lower coronavirus disease 2019 (COVID-19) vaccination rates among pregnant individuals in the United States (U.S.).

15 Sep 2022

CDC endorses ACIP recommendations for use of updated COVID-19 boosters

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendations for use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older.

15 Sep 2022

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

The phase 1/2b clinical trial on R21/Matrix-M malaria vaccine has recently reported the safety and efficacy of booster vaccination at 12 months.

15 Sep 2022

Bivalent recombinant vaccine protects against SARS-CoV-2 and influenza in animal models

In a new study, researchers developed a recombinant bivalent vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza viruses.

15 Sep 2022

Vaccine-derived poliovirus 2 detected in environmental samples in the UK and USA

Over the last few months, poliovirus 2 derived from the strain used in the Sabin vaccine (oral polio vaccine) has been repeatedly detected in environmental samples in the USA as well as in the UK. What does this signify?

15 Sep 2022

COVID-19's future is uncertain as infections increase and tracking decreases

Researchers review how the SARS-CoV-2 genome has changed throughout the COVID-19 pandemic.

14 Sep 2022

Study highlights the efficacy of MVA-BN booster vaccination in inducing durable B cell memory responses against monkeypox

In a new study, researchers assessed the immunogenicity, safety, and booster-efficacy of the Modified Vaccinia virus Ankara-Bavarian Nordic (MVA-BN) vaccine currently being used for immunization against monkeypox.

14 Sep 2022

Immunization News and Research

mRNA boosters associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone

Researchers computationally design immunogens to elicit antibodies against different SARS-CoV-2 variants

What is the vaccine efficacy of repeated influenza vaccinations?

What is the association between COVID-19 and type 1 diabetes?

First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine

What is the efficacy of the BCG vaccine against SARS-CoV-2 infection?

Virology of the human monkeypox virus

Prophylactic administration of SARS-CoV-2 specific immunoglobulin Y generated in chicken eggs displays protective effects in infected mice

Researchers report development of a self-assembled trimeric RBD subunit vaccine able to prevent SARS-CoV-2 infection

Study reveals improved immunogenicity and safety of bivalent Omicron-containing mRNA-1273.214 candidate booster vaccine

United States joins 30 other countries with circulating vaccine-derived poliovirus

The potential for measles and rubella elimination globally

An improved COVID-19 vaccine shows promise against Omicron in experimental models

COVID-19 vaccine safety concerns result in lower vaccination rates among pregnant individuals in the United States

CDC endorses ACIP recommendations for use of updated COVID-19 boosters

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

Bivalent recombinant vaccine protects against SARS-CoV-2 and influenza in animal models

Vaccine-derived poliovirus 2 detected in environmental samples in the UK and USA

COVID-19's future is uncertain as infections increase and tracking decreases

Study highlights the efficacy of MVA-BN booster vaccination in inducing durable B cell memory responses against monkeypox

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News